Concepedia

Publication | Open Access

Long-term safety in patients with recurrent ovarian cancer treated with niraparib versus placebo: Results from the phase III ENGOT-OV16/NOVA trial

51

Citations

13

References

2020

Year

References

YearCitations

Page 1